These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33626175)

  • 41. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
    Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
    Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and mutational spectrum of Charcot-Marie-Tooth disease type 2Z caused by MORC2 variants in Japan.
    Ando M; Okamoto Y; Yoshimura A; Yuan JH; Hiramatsu Y; Higuchi Y; Hashiguchi A; Mitsui J; Ishiura H; Fukumura S; Matsushima M; Ochi N; Tsugawa J; Morishita S; Tsuji S; Takashima H
    Eur J Neurol; 2017 Oct; 24(10):1274-1282. PubMed ID: 28771897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of c-Myc in the proliferation of MCF-7 human breast cancer cells induced by bHLH transcription factor DEC2.
    Wu Y; Sato H; Suzuki T; Yoshizawa T; Morohashi S; Seino H; Kawamoto T; Fujimoto K; Kato Y; Kijima H
    Int J Mol Med; 2015 Mar; 35(3):815-20. PubMed ID: 25524285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Time for MYC: Metabolism and Therapy.
    Dang CV
    Cold Spring Harb Symp Quant Biol; 2016; 81():79-83. PubMed ID: 28174256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MYC and DNMT3A-mediated DNA methylation represses microRNA-200b in triple negative breast cancer.
    Pang Y; Liu J; Li X; Xiao G; Wang H; Yang G; Li Y; Tang SC; Qin S; Du N; Zhang H; Liu D; Sun X; Ren H
    J Cell Mol Med; 2018 Dec; 22(12):6262-6274. PubMed ID: 30324719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells.
    Kim D; Hong A; Park HI; Shin WH; Yoo L; Jeon SJ; Chung KC
    J Cell Physiol; 2017 Dec; 232(12):3664-3676. PubMed ID: 28160502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells.
    Wang T; Qin ZY; Wen LZ; Guo Y; Liu Q; Lei ZJ; Pan W; Liu KJ; Wang XW; Lai SJ; Sun WJ; Wei YL; Liu L; Guo L; Chen YQ; Wang J; Xiao HL; Bian XW; Chen DF; Wang B
    Cell Death Differ; 2018 Dec; 25(12):2086-2100. PubMed ID: 29555977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
    Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
    Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.
    Xiao X; Huang X; Ye F; Chen B; Song C; Wen J; Zhang Z; Zheng G; Tang H; Xie X
    Sci Rep; 2016 Feb; 6():21735. PubMed ID: 26902416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.
    Wang X; Duan W; Li X; Liu J; Li D; Ye L; Qian L; Yang A; Xu Q; Liu H; Fu Q; Wu E; Ma Q; Shen X
    Oncotarget; 2015 Dec; 6(38):40959-69. PubMed ID: 26516926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability.
    Broecker-Preuss M; Becher-Boveleth N; Bockisch A; Dührsen U; Müller S
    J Transl Med; 2017 Jul; 15(1):158. PubMed ID: 28724379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
    Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
    Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.
    Li XX; Shi L; Zhou XJ; Wu J; Xia TS; Zhou WB; Sun X; Zhu L; Wei JF; Ding Q
    J Exp Clin Cancer Res; 2017 Apr; 36(1):49. PubMed ID: 28399911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MORC2 mutations cause axonal Charcot-Marie-Tooth disease with pyramidal signs.
    Albulym OM; Kennerson ML; Harms MB; Drew AP; Siddell AH; Auer-Grumbach M; Pestronk A; Connolly A; Baloh RH; Zuchner S; Reddel SW; Nicholson GA
    Ann Neurol; 2016 Mar; 79(3):419-27. PubMed ID: 26659848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
    Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
    Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leptin promotes fatty acid oxidation and OXPHOS via the c-Myc/PGC-1 pathway in cancer cells.
    Liu Q; Sun Y; Fei Z; Yang Z; Duan K; Zi J; Cui Q; Yu M; Xiong W
    Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):707-714. PubMed ID: 31187140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lactate Dehydrogenase A Governs Cardiac Hypertrophic Growth in Response to Hemodynamic Stress.
    Dai C; Li Q; May HI; Li C; Zhang G; Sharma G; Sherry AD; Malloy CR; Khemtong C; Zhang Y; Deng Y; Gillette TG; Xu J; Scadden DT; Wang ZV
    Cell Rep; 2020 Sep; 32(9):108087. PubMed ID: 32877669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.
    Bouillez A; Rajabi H; Pitroda S; Jin C; Alam M; Kharbanda A; Tagde A; Wong KK; Kufe D
    Cancer Res; 2016 Mar; 76(6):1538-48. PubMed ID: 26833129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ORAI3 silencing alters cell proliferation and cell cycle progression via c-myc pathway in breast cancer cells.
    Faouzi M; Kischel P; Hague F; Ahidouch A; Benzerdjeb N; Sevestre H; Penner R; Ouadid-Ahidouch H
    Biochim Biophys Acta; 2013 Mar; 1833(3):752-60. PubMed ID: 23266555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.